Pro Health Tips
Monday, 2 April 2018
New Anticancer Drug - Larotrectinib Shows 93 Percent Success Rate
Larotrectinib receives the FDA breakthrough therapy designation for treating patients with a specific fusion of two genes in the cancer cell, no matter what cancer type.
from Medindia Health News https://ift.tt/2J9AhAS
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Larotrectinib receives the FDA breakthrough therapy designation for treating patients with a specific fusion of two genes in the cancer cell, no matter what cancer type.
No comments:
Post a Comment